(Q36645479)

15 August 2017

1 reference

title

Serious adverse events and death associated with treatment using long-acting beta-agonists (English)

1 reference

15 August 2017

Fernando D Martinez

1

1 reference

15 August 2017

publication date

1 October 2006

1 reference

Clinical Reviews in Allergy & Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

31

1 reference

15 August 2017

issue

2-3

1 reference

15 August 2017

page(s)

269-278

1 reference

Association between asthma mortality and isoproterenol aerosols: a review

15 August 2017

cites work

1 reference

12 December 2020

Is there a problem with inhaled long-acting beta-adrenergic agonists?

1 reference

12 December 2020

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

1 reference

12 December 2020

Adverse effects of beta-agonists

1 reference

12 December 2020

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

1 reference

12 December 2020

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

1 reference

12 December 2020

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma

1 reference

12 December 2020

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.

1 reference

12 December 2020

beta-Adrenergic receptor polymorphisms and response to salmeterol

1 reference

12 December 2020

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

1 reference

12 December 2020

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

1 reference

12 December 2020

Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma

1 reference

12 December 2020

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

1 reference

12 December 2020

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

1 reference

12 December 2020

Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults

1 reference

12 December 2020

Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity

1 reference

12 December 2020

Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic

1 reference

12 December 2020

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:31:2:269

1 reference

Dimensions Publication ID

15 August 2017

1028474976

0 references

1 reference